Andrew Funderburk

Andrew Funderburk

Andrew Funderburk

Partner and Managing Director, Health Advances

Andrew is a leader of Health Advances’ biopharma practice. He specializes in helping companies formulate development, commercialization, and lifecycle management strategies to grow the value of products and franchises.

Andrew has led over one hundred projects for global biopharmaceutical companies, start-up biotechs, private equity investors, healthcare service businesses, and nonprofits. His therapeutic area experience spans oncology, autoimmune diseases, pulmonology, CNS diseases, gastroenterology, critical care, and many orphan conditions. He is also an expert in drug distribution for specialty products and has worked with drug manufacturers and pharmacies on their distribution channel strategies. In his nonprofit work, Andrew has assisted the Michael J. Fox Foundation and the National Parkinson Foundation with major strategic planning projects.

Work Experience

Andrew joined Health Advances in 2005 with a strong background in corporate strategy, finance, and strategic planning. Prior to Health Advances, Andrew worked with Michael Porter of the Harvard Business School on business strategy and healthcare policy, and with Monitor Group, where he split his time between the Pharmaceutical and Corporate Finance practices. He also worked in Genentech’s internal strategic planning group.

Education

Andrew earned an AB in economics, summa cum laude, and a minor in operations research from Princeton University, and an MBA with distinction from the Harvard Business School.

We are always available for a conversation.

*